VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 189 filers reported holding VERACYTE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $649,336 | -17.0% | 29,092 | -5.3% | 0.00% | 0.0% |
Q2 2023 | $782,537 | +45.3% | 30,734 | +27.2% | 0.00% | +50.0% |
Q1 2023 | $538,384 | -95.9% | 24,160 | -78.2% | 0.00% | -92.3% |
Q4 2022 | $13,036,802 | +2355.1% | 110,668 | +246.6% | 0.03% | +1200.0% |
Q3 2022 | $531,000 | -27.7% | 31,930 | -13.5% | 0.00% | -33.3% |
Q2 2022 | $734,000 | +84.4% | 36,896 | +155.8% | 0.00% | +50.0% |
Q1 2022 | $398,000 | -16.2% | 14,424 | +25.1% | 0.00% | 0.0% |
Q4 2021 | $475,000 | -6.1% | 11,529 | +5.8% | 0.00% | 0.0% |
Q3 2021 | $506,000 | +14.0% | 10,900 | -1.9% | 0.00% | 0.0% |
Q2 2021 | $444,000 | -16.4% | 11,106 | +12.4% | 0.00% | 0.0% |
Q1 2021 | $531,000 | -23.3% | 9,882 | -30.2% | 0.00% | -33.3% |
Q4 2020 | $692,000 | +38.1% | 14,150 | -8.2% | 0.00% | +50.0% |
Q3 2020 | $501,000 | +42.7% | 15,413 | +13.7% | 0.00% | 0.0% |
Q2 2020 | $351,000 | +14.0% | 13,550 | +6.8% | 0.00% | 0.0% |
Q1 2020 | $308,000 | – | 12,683 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |